- Quantum Surgical receives €30 million in financing from EIB
- Support for technology to treat inoperable tumours in abdomen and lungs
- Deal benefits from guarantee under European Commission’s InvestEU programme
French medical robotics company Quantum Surgical is borrowing €30 million from the European Investment Bank (EIB) to accelerate the worldwide commercialisation of a technology designed to treat abdominal and lung cancer with minimal invasiveness.
More than 4 million new abdominal and lung cancer cases are diagnosed worldwide every year. Several hundred patients have already been treated using Quantum Surgical’s technology, which combines robotics and artificial intelligence and is called Epione.
“This €30 million financing demonstrates Europe’s commitment to supporting innovation and promising technologies in the healthcare sector, which are essential for improving the lives and wellbeing of patients on a much larger scale,” said EIB Vice-President Ambroise Fayolle.
This financing follows a 2021 EIB loan for the commercial launch of Epione.
France: Medical robotics company Quantum Surgical gets EIB loan to advance tumour treatment